Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07206615

Spot Ex PMCF 01 Study

Post Market Clinical Follow-Up Study - Chart Review of the Spot Ex Endoscopic Marker

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Laborie Medical Technologies Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Post market clinical study that is a chart review of the Spot Ex Endoscopic Marker

Detailed description

This study is a medical chart review to confirm the safety and performance of the Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).

Conditions

Interventions

TypeNameDescription
OTHEREndoscopic markerStudy to confirm the safety and performance of the Laborie Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).

Timeline

Start date
2025-10-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-10-03
Last updated
2025-10-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07206615. Inclusion in this directory is not an endorsement.

Spot Ex PMCF 01 Study (NCT07206615) · Clinical Trials Directory